On this page we presented the REGN PE Ratio History information for Regeneron Pharmaceuticals' stock. The average REGN PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 30.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average REGN PE ratio history based on this TTM earnings result method is 24.8.

Let's now compare this REGN PE ratio history result, against the recent PE: when this page was posted on 4/9/2024, the most recent closing price for REGN had been 943.89, and the most recent quarterly earnings result, annualized, was 47.44. Meanwhile, the most recent TTM earnings summed to 43.78. From these numbers, we calculate the recent REGN PE on 4/9/2024 based on annualized quarterly EPS was 19.9. Based on REGN's history, that recent PE is low relative to the historical average, with the recent PE 34.8% lower than the historical average PE across our data set for Regeneron Pharmaceuticals. Looking at the recent REGN PE on 4/9/2024 based on TTM EPS, we calculate the ratio at 21.6. Based on REGN's history, that recent PE is low relative to the historical average, with the recent PE 12.9% lower than the average PE across our Regeneron Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting REGN PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for REGN, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for REGN, we start with the past four EPS numbers and we first sort them from lowest to highest: 10.09, 10.24, 11.59, and 11.86. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 10.24 and 11.59 — which gives us the median of 10.91. Basically the way to think about this 10.91 number is this: for the trailing four earnings reports, 10.91 marks the "middle ground" number where REGN has reported a value higher than 10.91 half the time, and has reported a value lower than 10.91 half the time. Annualizing that median value then gets us to 43.64/share, which we use as the denominator in our next PE calculation. With 943.89 as the numerator (as of 4/9/2024), the calculation is then 943.89 / 43.64 = 21.6 as the REGN PE ratio as of 4/9/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on REGN or any other given stock, valuation analysis for REGN can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Regeneron Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for REGN. Thanks for visiting, and the next time you need to research REGN PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.